Introduction
Magnetic nanoparticles (MNPs) open up a new range of feasible therapeutic possibilities for developing safe and effective drug delivery systems (DDSs) due to their advantages of synthesis, characterization, and tailoring the functional properties of nanoparticles (NPs) for drug delivery uses [1] [2] [3] [4] [5] [6] [7] [8] [9] . Moreover, MNPs can be manipulated by the outside magnetic field for many applications for pharmaceutical and biomedical analysis [10] . Magnetic iron oxide nanoparticles (SPIO NPs), a kind of new functional materials, have numerous advantages such as biocompatibility, chemical stability, and superparamagnetic behavior, allowing them to be the primary choice for biological and biomedical applications [11] . However, there are still several drawbacks of SPIO NPs, including weak physiological stability, fast blood clearance from the circulation, and lack of target specificity, which may limit their potential clinical application [12] .
Surface modification, one of the most outstanding approaches, has been studied for the purpose of overcoming the disadvantages of SPIO NPs, including amphiphilic molecules, bifunctional polymeric ligands, or biomolecules [13] . Among different types of synthetic and natural magnetic macromolecules for stabilizing magnetic NPs, protein and polysaccharides were found to be more promising based on their excellent characteristics of biocompatibility and biodegradability. Chitosan (CTS) has attracted attention for improving the dynamic stability of MNPs caused by its many health benefits, including high biocompatibility, relevant biodegradability, and low toxicity. According to the combined effect of two active groups (amino and hydroxyl groups) along the backbone of CTS, strategies for chemical modification of CTS are shown to be valuable tools for developing novel biocompatible materials with tailored chemo-physical properties. Despite the success of CTS in enhancing the stability of MNPs, CTS-grafted MNPs are mostly absorbed into the blood circulation, which is a major obstacle for pharmaceutical applications, especially in DDSs [14] [15] [16] . Therefore, polyethylene glycol (PEG), an extremely hydrophilic polymer, has been commonly employed to optimize the stability of DDSs in the bloodstream by increasing the water solubility of CTS. As a result, PEG grafted onto the CTS chain not only improves the biocompatibility of CTS but also avoids the absorption of protein and evades from the reticuloendothelial system. More importantly, this conjugation can be used to increase the solubility of water-insoluble drugs for controlled drug delivery carriers [17] [18] [19] . For instance, Najafabadi and co-workers reported a simple new method of methoxyl polyethylene glycol (mPEG) conjugated CTS (mPEG-CTS) for enhancing the solubility of CTS and controlling ibuprofen delivery. The result showed that the release of ibuprofen from mPEG-CTS NPs were much lower than CTS alone. This study demonstrated that mPEG-CTS NPs can be a promising candidate for water-insoluble DDSs [20] . Additionally, Qu et al. successfully developed magnetic nanocarriers for controlled 10-hydroxycamptothecin (HCPT) delivery. In detail, PEG chains were conjugated to the magnetic particles (CTS-Fe 3 O 4 ) to enhance the biocompatibility of PEG-CTS-Fe 3 O 4 . The result of this study indicated that HCPT was released in a controlled manner up to 48 h. As a consequence, PEG-CTS-Fe 3 O 4 could possibly be utilized as a stable MNP for controlling HCPT delivery in cancer treatment [21] .
In this study, magnetic nanocarriers for paclitaxel (PTX) was prepared by using Fe 3 O 4 NPs as cores and mPEG-CTS as polymer outer layers (PTX/Fe 3 O 4 @CTS-mPEG). In addition, the structural and morphological characterizations of the obtained samples were determined by proton nuclear magnetic resonance ( 1 H NMR) spectroscopy, Fourier transform infrared (FT-IR), X-ray diffraction (XRD), and transmission electron microscopy (TEM). Particularly, either the drug loading or drug release behavior of PTX/Fe 3 O 4 @CTS-mPEG was also evaluated. This study is expected to improve the stability of magnetic NPs for controlled delivery systems in cancer therapy. 
Preparation of CTS-mPEG
CTS-grafted-mPEG (CTS-mPEG) was synthesized by utilizing PNC as a cross-linking agent, as previously reported, with modification [22, 23] . Briefly, 0.8 g mPEG was melted under vacuum at 65°C, followed by adding 0.05 g PNC under constant stirring for 6 h, and the temperature was then cooled down to 40°C. After that, 20 ml THF and 10 ml deionized water were added into the solution to remove unreacted mPEG and PNC. At that period of time, CTS solution was prepared at pH 5 by using HCl solution (1 m). The mPEG-PNC solution was slowly dropped into the CTS solution and the reaction was then kept at room temperature for 24 h. The solution was dialyzed by using a dialysis membrane (MWCO 12-14 kDa; Spectrum Laboratories Inc., USA) and lastly lyophilized to obtain CTS-mPEG. = 1:2) was added into the three-necked flask and constantly stirred under nitrogen. NH 4 OH solution (10%, w/w) was injected into the mixture, and the reaction was maintained at room temperature under vigorous stirring for 1 h until the pH reached 10. The color of the solution changed to dark black. Thereafter, the precipitate was isolated by using a super magnet bar and then rinsed with deionized water several times.
Preparation of Fe 3 O 4 and Fe 3 O 4 @CTS-mPEG MNPs
Fe 3 O 4 @CTS-mPEG MNPs were formed by adding Fe 3 O 4 solution (154 mg Fe 3 O 4 dissolved in 50 ml deionized water) into CTS-mPEG solution (300 mg CTS-mPEG dissolved in 50 ml deionized water) at room temperature under ultrasonication for 6 h. During this process, CTS-mPEG was adsorbed onto the surface of Fe 3 O 4 NPs, and the obtained substance was centrifuged and lyophilized for further use.
Characterization
The chemical structures of the polymers corresponding to the synthetic procedure were analyzed by 
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In vitro release of PTX from Fe 3 O 4 @CTS-mPEG MNPs was performed in phosphate buffer saline (PBS) containing 0.5 wt.% Tween-80 (0.01 m, pH 7.4) at 37°C using a dialysis method. One milliliter of this suspension (PTX content, 0.3 mg/ml) was transferred into a dialysis bag (MWCO = 12-14 kDa; Spectrum Laboratories Inc., USA) and then immersed into 14 ml fresh medium at 37°C. The samples were placed in an orbital shaker bath, which was maintained at 37°C and horizontally shaken at 100 rpm. At predetermined time intervals, 14 ml of the released medium was withdrawn, filtered (pore size = 0.20 μm), and replaced with an equal amount of fresh medium. Following lyophilization of the collected medium, the amount of PTX released from Fe 3 O 4 @CTS-mPEG MNPs was determined using high performance liquid chromatography. Furthermore, the same procedure was repeated at 45°C, pH 7.4, to examine the hyperthermic effect of Fe 3 O 4 @CTS-mPEG MNPs.
Results and discussion
The synthesis of CTS-mPEG was performed by conjugating mPEG-PNC with the CTS backbone. The conjugation ratio of PNC to mPEG was approximately 98%, as reported in our previous studies. CTS-mPEG was analyzed by (440)]. These six diffraction peaks comprise the standard pattern for crystalline magnetite with a spinal structure [24] . Moreover, the insignificant influence of CTS-mPEG on the core of samples was also indicated by XRD data. , respectively. In addition, the increased intensity of the peaks at around 2924 and 1100 cm -1 showed the CH 2 groups and C-O-C stretch of mPEG, respectively. Importantly, a new strong peak that appeared at 1720 cm -1 was assigned to the carbonyl band. The characteristic peaks of Fe 3 O 4 at 571 and 578 cm -1 could be obtained in Figure 4 (ii) and (iii). The presence of Fe 3 O 4 NPs was identified by the O-H stretch vibration at 3416 and 3420 cm was assigned to the C-O alcoholic groups of CTS. Further, the peaks at around 2925 and 3430 cm -1 were attributed to the C-H stretching band and the amino groups of CTSmPEG, respectively. These results showed that CTS-mPEG was prepared and attached onto the Fe 3 O 4 NP surface. MNPs have mostly been used to control drug release with an external magnetic field [26] . The in vitro release of PTX from Fe 3 O 4 @CTS-mPEG was carried out in PBS (pH 7.4) at 37°C and 45°C ( Figure 6 ). The coated NPs [21] . The release behavior of PTX could be explained by the flexible and hydrophilic PEG chains on the surface of Fe 3 O 4 @CTS-mPEG, which enhance the diffusion resistance of PTX. However, after incubation with PBS at 45°C, the cumulative release amount of PTX was 54.6%, compared with 59.9% and 65.8% of HCPT from PEG (5000)-CTS-Fe 3 O 4 and PEG (2000)-CTS-Fe 3 O 4 , respectively [21] . The release behavior of PTX in the obtained NPs at 37°C and 45°C was significantly different. In other words, the diffusion rate of PTX from Fe 3 O 4 @CTS-mPEG NPs was facilitated by high temperatures. According to these results, Fe 3 O 4 @CTS-mPEG might be conveniently available for both hyperthermia (42-45°C) and chemotherapy. Such combination therapy is very effective when using an external alternating magnetic field for magnetic targeted drug delivery. Overall, Fe 3 O 4 @CTS-mPEGs may serve as stable MNPs with dual therapeutic effects in cancer treatment.
Conclusion
In this study, CTS-mPEGs have been successfully conjugated and coated onto Fe 3 O 4 NPs with 20 nm diameter. The water-insoluble PTX was effectively loaded into Fe 3 O 4 @ CTS-mPEG NPs and slowly released up to 96 h. Furthermore, the coated NPs also showed their potential applications in cancer hyperthermia (42-45°C) therapy. These results suggest the promising potential of Fe 3 O 4 @CTS-mPEG NPs as a stable magnetic delivery system with dual therapeutic effects (hyperthermia and chemotherapy) for the treatment of cancer.
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